Creating a database for sarcoma research
Development of a Monocentric and Prospective Clinical and Biological Database in Sarcoma
This study is creating a database to collect blood and tissue samples from people with liposarcoma to help researchers learn more about the disease and find new treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 450 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle Academic / other |
| Locations | 1 site (Montpellier, Herault) |
| Trial ID | NCT04458792 on ClinicalTrials.gov |
What this trial studies
This project aims to establish a clinical and biological database that collects blood and tissue samples from patients with sarcoma, specifically liposarcomas. The database will include clinical data to enhance understanding of sarcoma and facilitate the development of new treatments. By focusing on the Mdm2 gene and its role in liposarcoma, the study seeks to uncover insights that could lead to innovative therapeutic strategies. The collaboration with the U1194 INSERM unit will support ongoing research into various types of sarcomas.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 who have undergone surgery for sarcoma and are willing to provide blood samples.
Not a fit: Patients who are pregnant, under guardianship, or unable to comply with study requirements may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to improved treatment options and outcomes for patients with sarcoma.
How similar studies have performed: While this approach is focused on a specific type of sarcoma, similar studies have shown promise in utilizing biological databases for cancer research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * men or women \> 18 years * Patient treated by surgery for : a primitive sarcoma and/or local relapse sarcoma and/or metastatic localisation of sarcoma * patient accepted blood sample * patient treated by radiotherapy before or after the surgery * Patient signed informed consent Exclusion Criteria: * Patient not affiliated to french Social Protection system * Patient under guardianship * Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons * Pregnancy and/or feeding * Patient take care in an Emergency Situation
Where this trial is running
Montpellier, Herault
- Icm Val D'Aurelle — Montpellier, Herault, France (Recruiting)
Study contacts
- Study coordinator: Aurore MOUSSION
- Email: DRCI-icm105@icm.unicancer.fr
- Phone: 4 67 61 31 02
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.